SRF Partners With Chemours for Fluoropolymer Manufacturing

🤝

Ltd. has joined hands with Chemours Co. to manufacture fluoropolymers and fluoroelastomers at its Dahej facility. Production is set to begin within 12 months, with revenue growth expected from FY27. The partnership requires no upfront capital from Chemours and will utilize SRF’s existing PTFE facility, currently running at 50–60% capacity. Analyst views remain mixed, with Citi and UBS maintaining ‘sell’ while DAM Capital retains a ‘buy’.